Prognostic value of plasmablastic morphology and p21, p53 and Cyclin D1 expression in myeloma cells: retrospective study of 122 patients with newly diagnosed multiple myeloma-Reference-Cited by-同舟云学术

Prognostic value of plasmablastic morphology and p21, p53 and Cyclin D1 expression in myeloma cells: retrospective study of 122 patients with newly diagnosed multiple myeloma

Published:2021-01-01 Issue:1 Volume:35 Page:1941-1947
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Nazarovs Jurijs¹²³,Breikša Austra¹²⁴,Kleina Regīna³,Lejniece Sandra⁵⁶,Voicehovska Jūlija⁵⁷,Momekov Georgi⁸^ORCID

Affiliation:

1. Pathology Centre, Riga East University Hospital, Rīga, Latvia

2. Pauls Stradins Clinical University Hospital, Pathology Institute, Rīga, Latvia

3. Department of Pathology, Riga Stradins University, Rīga, Latvia

4. Department of Pathology, University of Latvia, Rīga, Latvia

5. Department of Internal Diseases, Riga Stradins University, Rīga, Latvia

6. Hematology and Chemotherapy Clinic, Riga East University Hospital, Rīga, Latvia

7. Renal Disease and Kidney Replacement Therapy Clinics, Riga East University Hospital, Rīga, Latvia

8. Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria

Publisher

Informa UK Limited

Subject

Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2022.2041484

Reference23 articles.

1. Multiple Myeloma Genomics – A Concise Review

2. Pildava S. 2012. Doctus database (in Latvian) on the World Wide Web [last accessed 2020 Jun 10]. Retrieved from https://www.doctus.lv/2012/7/multipla-mieloma

3. International Staging System for Multiple Myeloma

4. Prognostic significance of bone marrow histology in multiple myeloma

5. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort